RXR is an essential component of the oncogenic PML/RARA complex in vivo

Jun Zhu1, Rihab Nasr, Laurent Pérès

  • 1CNRS/University Paris VII UMR 7151, laboratoire associé N11 de la Ligue contre le Cancer, Hôpital St. Louis, 1, avenue Claude Vellefaux, 75475 Paris Cedex 10, France.

Cancer Cell
|July 7, 2007
PubMed

Insights

Retinoic acid receptor (RXR) is unexpectedly crucial for PML/RARA

Area of Science:

  • Molecular Biology
  • Hematopoiesis
  • Cancer Biology

Background:

  • The PML/RARA oncoprotein drives acute promyelocytic leukemia (APL).
  • PML/RARA's interaction with coreceptors like RXR is critical for its function.
  • RXR's precise role in PML/RARA-mediated leukemogenesis remains incompletely understood.

Purpose of the Study:

  • To investigate the essential role of RXR in PML/RARA-induced APL development in vivo.
  • To elucidate how RXR influences PML/RARA's DNA binding and transcriptional activity.
  • To determine RXR's impact on differentiation therapy for APL.

Main Methods:

  • Generation of transgenic mouse models expressing wild-type or RXR-binding-defective PML/RARA.
  • Ex vivo transformation of primary hematopoietic progenitors.
  • Analysis of APL development, differentiation, and gene expression.
  • Assessment of PML/RARA and RXR posttranslational modifications.

Main Results:

  • PML/RARA mutants lacking RXR binding fail to induce APL in mice but transform cells ex vivo.
  • RXR enhances PML/RARA's DNA binding and is essential for rexinoid-induced differentiation.
  • Absence of RXR leads to monocytic differentiation instead of granulocytic differentiation in treated cells.
  • PML/RARA promotes RXR sumoylation, suggesting a role in deregulated transcription.

Conclusions:

  • RXR is unexpectedly required for PML/RARA's in vivo leukemogenic activity.
  • RXR plays a critical role in PML/RARA-driven APL pathogenesis and differentiation.
  • Targeting RXR interactions may offer novel therapeutic strategies for APL.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...